tradingkey.logo
搜索

AVITA Medical Inc

RCEL
添加自选
5.060USD
+0.390+8.35%
收盘 07/02, 13:00美东报价延迟15分钟
778.65M总市值
亏损市盈率 TTM

AVITA Medical Inc

5.060
+0.390+8.35%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+8.35%

5天

+29.08%

1月

+20.76%

6月

+45.82%

今年开始到现在

+46.67%

1年

-2.13%

关键数据
4.610今开
5.100最高
615.46K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.40%换手率
4.670昨收
4.585最低
2.29M成交额
亏损市盈率静
-33.61市净率
0.00%股息率 TTM
-74.88%ROA
7.12052周最高
1.83量比
-61.84M净利润
153.88M总股本
-1.5635每股收益TTM
1.88Beta
-1746.27%ROE
3.22052周最低
11.03%振幅
82.00%毛利率
778.65M总市值
2.72回报/风险
4.50%风险率

TradingKey AVITA Medical Inc股票评分

单位: USD 更新时间: 2026-07-01

操作建议

AVITA Medical Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名79/387位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价7.00。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

AVITA Medical Inc评分

相关信息

行业排名
79 / 387
全市场排名
188 / 4564
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看好

AVITA Medical Inc亮点

亮点风险
AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
业绩高增长
公司营业收入稳步增长,连续3年增长42.81%
业绩增长期
公司处于发展阶段,最新年度总收入71.61M美元
利润高增长
公司净利润处于行业前列,最新年度总收入71.61M美元
估值合理
公司最新PE估值-2.99,处于3年历史合理位
机构减仓
最新机构持股6.52M股,环比减少17.59%

分析师目标

根据 4 位分析师
买入
评级
4.833
目标均价
+13.73%
涨幅空间

AVITA Medical Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

AVITA Medical Inc简介

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
公司代码RCEL
公司AVITA Medical Inc
CEOVance (Cary G)
网址https://www.avitamedical.com/

常见问题

AVITA Medical Inc(RCEL)的当前股价是多少?

AVITA Medical Inc(RCEL)的当前股价是 5.06。

AVITA Medical Inc的股票代码是什么?

AVITA Medical Inc的股票代码是RCEL。

AVITA Medical Inc股票的52周最高点是多少?

AVITA Medical Inc股票的52周最高点是7.12。

AVITA Medical Inc股票的52周最低点是多少?

AVITA Medical Inc股票的52周最低点是3.22。

AVITA Medical Inc的市值是多少?

AVITA Medical Inc的市值是778.65M。

现在AVITA Medical Inc(RCEL)的股票是买入、持有还是卖出?

根据分析师评级,AVITA Medical Inc(RCEL)的总体评级为买入,目标价格为4.83。

AVITA Medical Inc(RCEL)股票的每股收益(EPS TTM)是多少

AVITA Medical Inc(RCEL)股票的每股收益(EPS TTM)是-1.74。